Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | AGXT | P21549 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80897 | 0.83 | TSHR (0.41) | TSHRKMT2AIDO1AGXTALDH1A1 | |
| SCHEMBL2252915 | 0.83 | TSHR (0.41) | TSHRKMT2AIDO1AGXTALDH1A1 | |
| SCHEMBL2261012 | 0.80 | TSHR (0.39) | TSHRKMT2AIDO1AGXTALDH1A1 | |
| SCHEMBL2240873 | 0.80 | KMT2A (0.40) | TSHRKMT2AIDO1ALDH1A1MAPK1 | |
| SCHEMBL24027339 | 0.80 | TSHR (0.39) | TSHRKMT2AIDO1AGXTALDH1A1 | |
| SCHEMBL24027472 | 0.77 | TSHR (0.36) | TSHRKMT2AIDO1AGXTALDH1A1 | |
| SCHEMBL16171402 | 0.76 | TSHR (0.41) | TSHRIDO1AGXTALDH1A1MAPK1 | |
| SCHEMBL24027553 | 0.74 | KMT2A (0.35) | TSHRKMT2AIDO1ALDH1A1CA1 | |
| SCHEMBL388026 | 0.73 | TSHR (0.52) | TSHRKMT2AIDO1AGXTALDH1A1 | |
| SCHEMBL14702031 | 0.73 | TSHR (0.52) | TSHRKMT2AIDO1AGXTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-11840551-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) | 2023-12-12 | — | — | US | disclosed |
| US-11773131-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) | 2023-10-03 | — | — | US | disclosed |
| US-11707519-B2 | Phosphorylated heptose compounds: process for their preparation and use | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND (IE) | 2023-07-25 | — | — | US | disclosed |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| EP-4171490-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-05-03 | — | — | EP | disclosed |
| WO-2022003040-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2022-01-06 | — | — | WO | disclosed |
| WO-2020023628-A1 | COMPOUNDS, DERIVATIVES, AND ANALOGS FOR CANCER | HYGIA PHARMACEUTICALS, LLC (US) | 2020-01-30 | — | — | WO | disclosed |
| WO-2017025244-A1 | COSMETIC PROCESS FOR TREATING KERATIN MATERIALS | L'OREAL (FR) | 2017-02-16 | — | — | WO | disclosed |
| WO-2016076437-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2016-05-19 | — | — | WO | disclosed |
| US-20150024938-A1 | METALLOENZYME INHIBITOR COMPOUNDS | Mycovia Pharmaceuticals, Inc. | 2015-01-22 | — | — | US | disclosed |
| US-20150004666-A1 | METALLOENZYME INHIBITOR COMPOUNDS | VIAMET PHARMACEUTICALS, INC. (US) | 2015-01-01 | — | — | US | disclosed |
| US-20130224830-A1 | EGGSHELL MEMBRANE SOLUBILIZATION METHOD USING ENZYMES | AMANO ENZYME INC. (JP) | 2013-08-29 | — | — | US | disclosed |
| EP-2612922-A1 | EGGSHELL MEMBRANE SOLUBILIZATION METHOD USING ENZYMES | Amano Enzyme Inc. (JP) | 2013-07-10 | — | — | EP | disclosed |
| WO-2011089985-A1 | COSMETIC COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2011-07-28 | — | — | WO | disclosed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | disclosed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | disclosed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150024938-A1 | METALLOENZYME INHIBITOR COMPOUNDS | MGAM, SOD1, CAT | TSHR 3406/4885KMT2A 1405/4885IDO1 951/4885 |
| US-11707519-B2 | Phosphorylated heptose compounds: process for their preparation and use | PPP6C, G6PD, PFKFB1 | TSHR 4697/4885KMT2A 2776/4885IDO1 1089/4885 |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | KRT18, CKAP4, VIM | TSHR 4711/4885KMT2A 767/4885IDO1 3623/4885 |
| US-11840551-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | PHKA1, PHKA2, PRKCA | TSHR 2816/4885KMT2A 3054/4885IDO1 1752/4885 |
| US-20150004666-A1 | METALLOENZYME INHIBITOR COMPOUNDS | MMEL1, GPX1, MPO | TSHR 1086/4885KMT2A 1886/4885IDO1 634/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | TSHR 4245/4885KMT2A 165/4885IDO1 3857/4885 |
| US-11773131-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | PHKA1, PHKA2, PRKCA | TSHR 2816/4885KMT2A 3054/4885IDO1 1752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.